Journal of Cancer Metastasis and Treatment
OAE Publishing Inc. · United States · Est. 2015
✓ Indexed in the Web of Science Core Collection (ESCI) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.
See the official Impact Factor & quartile on the journal’s page ↗The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3 · Scopus CiteScore 2.7. Source: Clarivate Journal Citation Reports.
Aims & Scope
The Journal of Cancer Metastasis and Treatment (JCMT) is an international, open-access, peer-reviewed journal that publishes original research, reviews, case reports, and commentaries on all aspects of cancer metastasis and treatment. The journal aims to provide a platform for researchers and clinicians to share their findings and insights on the prevention, diagnosis, and treatment of cancer. The journal covers a wide range of topics, including but not limited to, cancer biology, molecular oncology, cancer genetics, cancer immunology, cancer pharmacology, cancer imaging, cancer surgery, radiation oncology, medical oncology, and palliative care.
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Subject Classification
Web of Science Categories
Scopus Categories
Frequently asked questions about Journal of Cancer Metastasis and Treatment
Is Journal of Cancer Metastasis and Treatment a predatory journal?
PubScope has no integrity flags on record for Journal of Cancer Metastasis and Treatment: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of Journal of Cancer Metastasis and Treatment?
Journal of Cancer Metastasis and Treatment is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. As an open alternative, its Scopus CiteScore is 2.7.
Is Journal of Cancer Metastasis and Treatment indexed in Scopus and Web of Science?
Journal of Cancer Metastasis and Treatment is indexed in Web of Science, Scopus.
What is the aims and scope of Journal of Cancer Metastasis and Treatment?
The Journal of Cancer Metastasis and Treatment (JCMT) is an international, open-access, peer-reviewed journal that publishes original research, reviews, case reports, and commentaries on all aspects of cancer metastasis and treatment. The journal aims to provide a platform for researchers and clinicians to share their findings and insights on the prevention, diagnosis, and treatment of cancer. The journal covers a wide range of topics, including but not limited to, cancer biology, molecular oncology, cancer genetics, cancer immunology, cancer pharmacology, cancer imaging, cancer surgery, radia
You May Also Like
See all →Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref